Cambridge Healthtech Institute Announces its Inaugural Physicochemical Property Analysis

March 6, 2012 - PRLog -- This two day event takes place April 18-19, 2012 in San Diego, CA. The event focuses on the optimization of physical properties of a compound is fundamental to the drug discovery process, mainly due to their influence on absorption and distribution in vivo. This provides insight into the in vivo transport processes and knowing the properties will help with choosing the optimal compounds for the task. It saves costs and time when compounds are being properly analyzed in the design stage before they are moving into development, as it is important to consider questions such as how hydrophobicity will affect the solubility of a drug down the line or how the charge of the compound interacts with the absorption by a transport mechanism. Also, the use of predictive models is important, but again, without consideration of the actual physical chemical property of the new compound, the analyses will be based on a different set of data. This meeting will discuss what it takes to create selective and efficacious compounds and to understand the biological data by analyzing the physicochemical properties early on.

Speakers Include:  (partial listing)

- Gerald Maggiora, Ph.D., Adjunct Professor, College of Pharmacy at the University of Arizona; Professor in   Residence, Translational Genomics Research Institute

- Martin Edwards, Ph.D., Vice President and Head of Oncology Medicinal Chemistry, Pfizer

-Ernesto Freire, Ph.D., Henry Walters Professor, Johns Hopkins University

- Robert J. Young, Ph.D., GlaxoSmithKline

- Alan P. Hill, Ph.D., Team Leder, PhysChem, Department of Analytical Chemistry, GlaxoSmithKline, Stevenage UK

- Marcel Verdonk, Ph.D., Director, Computational Chemistry and Informatics, Astex Therapeutics, Inc.

- Terry Stouch, Ph.D., President, R&D, Science for Solutions, LLC

- Jianwen Fang, Ph.D., Associate Scientist, Director, Applied Bioinformatics Laboratory, The University of Kansas

For more information, or to register, please visit http://www.drugdiscoverychemistry.com/dch_content.aspx?id....  Register by March 16 to save!

About Cambridge Healthtech Institute (www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
Tracey Fielding
Marketing Manager
Cambridge Healthtech Institute
tfielding@healthtech.com

# # #

Since 1992, Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.